Skip to Main Content
Skip Nav Destination

Ahead of Print

case report April 15 2021
First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis
letter April 9 2021
Checkpoint Inhibitors in Checkmating Rare Cancers
review article March 26 2021
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
review article January 29 2021
Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?
Article Commentary November 16 2020
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining
Brief Report November 13 2020
The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers
Brief Report September 29 2020
Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy
review article September 14 2020
The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer
Close Modal

or Create an Account

Close Modal
Close Modal